November 9-11, 2020 | Virtual Conference

Speakers

Judith Zander, M.D.

Director
Office of Pharmacovigilance and Epidemiology, OSE, CDER, FDA

Judith (Judy) Zander M.D. is the Director of the Office of Pharmacovigilance and Epidemiology (OPE), in the Office of Surveillance and Epidemiology (OSE), in the Center for Drug Evaluation (CDER) at the U.S. Food and Drug Administration (FDA).She oversees the Divisions of Pharmacovigilance 1 and 2 and the Divisions of Epidemiology 1 and 2. Judy joined FDA in January 2017. She has more than 20 years of pharmaceutical industry in leadership roles in drug safety and risk management.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content